|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
SkinEthic Laboratories Quoted On The Paris Stock Market
10/19/2005 5:08:46 PM
The Nice laboratory SkinEthic can now hear its name called in trading offices throughout the world, having made its Stock Market debut at a minimum price of €6 per share on July 16. The company, founded in 1992 by biologist Martin Rosdy, Ph.D., specializes in the reproduction of human tissue for laboratory testing. The Initial Public Offering is a big success for SkinEthic, which until now has always been self-financed. Profitable by its second year, SkinEthic sales reached €1.63 million by 2003, a figure which the company expects to increase by 14.5% in 2004 and 26.3% in 2005. SkinEthic reconstitutes human tissue models – primarily epidermal and mucosal tissue – using original cell-culture procedures. Cells are grown in a physiologically natural environment, so the tissues obtained behave like human tissues when treated with irritating, pharmacologically active products. With an array of tissue products perfected, the company is now using its patented technology to reconstitute new models, including skin pathologies and 3D liver tissues. SkinEthic enters the free market now to increase its visibility at a strategic time in the testing market. By 2009, the European Union will no longer allow the sale of cosmetics tested on animals. As this decision is predicted to have an influence on pharmaceutical and chemical testing as well, SkinEthic positions itself to provide testing alternatives to animal and human preclinical testing to laboratories worldwide. Labs such as Safepharm, GlaxoSmithKline, Novartis, Pfizer and Johnson & Johnson have already verified the products' effectiveness and reliability. More information : http://www.skinethic.com
|
|
|
|
|
|
|
|
|
|
|